All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Spontaneous miscarriage, which afflicts 10% to 20% of pregnant women \[[@pone.0166892.ref001]--[@pone.0166892.ref004]\], is a distressing experience and a common complication in early pregnancy \[[@pone.0166892.ref005], [@pone.0166892.ref006]\]. To make matters worse, 1% to 5% of women will suffer two or more consecutive, unexplained pregnancy losses with the same partner prior to the 20th week of gestation \[[@pone.0166892.ref007], [@pone.0166892.ref008]\]. This is called idiopathic recurrent miscarriage (IRM) \[[@pone.0166892.ref009]\]. IRM is related to a variety of causes \[[@pone.0166892.ref010]\], among which the disturbance of the maternal homeostatic balance between the Th1 and Th2 cytokine system, is best studied \[[@pone.0166892.ref011]--[@pone.0166892.ref013]\]. This balance is maintained by a series of cytokines \[[@pone.0166892.ref014]\]. It has been reported that Th~1~ cytokines are detrimental and associated with IRM, whereas Th~2~ cytokines are not \[[@pone.0166892.ref015], [@pone.0166892.ref016]\].

As a pro-inflammatory Th1 cytokine, tumor necrosis factor alpha (TNF-α) is mapped in chromosome 6p21.3 and mainly secreted by mono-nuclear phagocytes, lymphocytes, and natural killer (NK) cells \[[@pone.0166892.ref017]\]. Some researches have demonstrated that TNF-α is implicated in the development of IRM \[[@pone.0166892.ref018]--[@pone.0166892.ref021]\], possibly by inducing the apoptosis of trophoblasts and promoting the expression of apoptotic genes in the human fetal membrane \[[@pone.0166892.ref022], [@pone.0166892.ref023]\]. Moreover, the production of TNF-α is mainly controlled by genes, whereas mutations of these genes could result in changes of TNF-α level, especially in the promoter region \[[@pone.0166892.ref024], [@pone.0166892.ref025]\]. Therefore, polymorphisms in this region may be associated with IRM risk. And a bunch of studies have been performed to evaluate the association between TNF-α promoter polymorphisms and IRM risk \[[@pone.0166892.ref026]--[@pone.0166892.ref050]\].

Among all the genetic variants in this region, *TNF-α* -308G/A (rs1800629) is most studied \[[@pone.0166892.ref028]--[@pone.0166892.ref050]\]. However, the results of these studies are inconsistent and often conflicting. Although one meta-analysis of 7 studies in 2009 \[[@pone.0166892.ref048]\], another one of 12 studies in 2012 \[[@pone.0166892.ref049]\], and the third one of 10 studies in 2016 \[[@pone.0166892.ref050]\] have been conducted, their conclusions were conflicting and unreliable due to the inclusion of studies deviating significantly from Hardy-Weinberg equilibrium (HWE) \[[@pone.0166892.ref039], [@pone.0166892.ref040]\], and studies without sufficient data to calculate HWE \[[@pone.0166892.ref044]--[@pone.0166892.ref047]\]. Meanwhile, a missing study \[[@pone.0166892.ref032]\] in the previous meta-analyses and a couple of new studies with different results \[[@pone.0166892.ref038], [@pone.0166892.ref041], [@pone.0166892.ref042]\] were found by us during the investigation. Therefore, we conducted this study to obtain more concrete and conclusive conclusions concerning the correlation between the *TNF-α* -308G/A polymorphism and IRM through a comprehensive and robust meta-analysis.

Materials and Methods {#sec006}
=====================

The present meta-analysis was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidance ([S1 Table](#pone.0166892.s010){ref-type="supplementary-material"}). No review protocol was registered for this study.

Identification of eligible trials {#sec007}
---------------------------------

Relevant articles were identified by a comprehensive search of the following electronic databases through July 2016: PubMed, Cochrane Library, Embase. The search terms included the synonyms of miscarriage, tumor necrosis factor and polymorphism ([S1 File](#pone.0166892.s005){ref-type="supplementary-material"}). The SNP number (rs1800629) was also searched in combination with the synonyms of miscarriage. In addition, Google Scholar, ClinicalTrial.gov and reference lists of relevant articles were also screened by two authors independently to collect the randomized controlled trials (RCTs) published.

Inclusion and exclusion criteria {#sec008}
--------------------------------

For all the relevant literature, the following inclusion criteria were adopted: 1) case-control designed studies or retrospective cohort studies with clear inclusion criteria; 2) data on allele and genotype frequencies provided; and 3) information on DNA genotyping method and characteristics of cases and controls included. Studies without genotype data or with duplicate data were excluded. Letters, case reports, editorials, review articles, conference abstracts, and animal studies were also excluded. Eligible studies were selected by the same two authors independently by screening the title, abstract, and full article based on the above criteria. Disputes were solved by consultation.

Data extraction {#sec009}
---------------

From all eligible studies, the following data were extracted: last name of the first author, publication date, country, ethnicity, mean age and source of the cases and controls, total sample size, genotype frequencies, and genotyping method. For each study, the HWE of the control group was computed from the genotype frequencies extracted above, and studies with *p* \<0.05 were considered as significantly deviating from the HWE and would be excluded from this meta-analysis. If a study had subgroups, each subgroup would be listed as a separate study. Two authors completed the whole process independently. If differences existed, data would be rechecked independently by the two authors. Further discrepancies would be referred to a third author. To obtain necessary missing data, authors were contacted via e-mail.

Quality assessment {#sec010}
------------------

The quality of each study was assessed using the assessment scale adapted from Peng et al. \[[@pone.0166892.ref051]\] for the present meta-analysis ([Table 1](#pone.0166892.t001){ref-type="table"}). Each study was scored and labelled as either low quality (score ≤6) or high quality (score \>6) based on items such as the definition of IRM adopted, representativeness of controls, description of genotyping method, mean age of cases, and total sample size. The quality assessment was performed by two authors independently, and disagreements were settled by consultation.

10.1371/journal.pone.0166892.t001

###### Scale for quality assessment of studies included.

![](pone.0166892.t001){#pone.0166892.t001g}

  Criteria[^a^](#t001fn001){ref-type="table-fn"}   Score
  ------------------------------------------------ -------
  IRM definition                                   
      ≥3 consecutive miscarriages                  1
      ≥2 consecutive miscarriages                  0
  Representativeness of controls                   
      Population-based (PB)                        2
      Hospital-based(HB)                           1
      Not described                                0
  Genotyping method                                
      Described                                    1
      Not described                                0
  Mean age of cases                                
      ≤ 35                                         3
      ≤ 40                                         1
      \> 40 or not described                       0
  Total sample size                                
      ≥ 500                                        3
      ≥ 200                                        2
      ≥ 100                                        1
      \< 100                                       0

^a^ These criteria are unfit for studies inconsistent with HWE.

Statistical analysis {#sec011}
--------------------

Based on the genotype frequencies of cases and controls in each study, we conducted a series of overall meta-analyses using the following five genetic models: the homozygote model (AA vs. GG), the heterozygote model (GA vs. GG), the recessive model (AA vs. GA + GG), the dominant model (AA + GA vs. GG), and the allelic model (A vs. G). Then, using the odd ratio (OR) and confidence interval (CI) produced, we evaluated the association between the above genetic models and IRM risk. The overall significance of the association was calculated by a paired z-test, and a *p* value \< 0.05 was considered significant. Heterogeneity among studies was computed by the Q statistic and the *I*^*2*^ statistic. For each study, either the fixed-effects model or the random-effects model was used, based on the *P*~*Q*~ value. If the *P*~*Q*~ value was \>0.1, the former was adopted; otherwise, the latter was chosen. To investigate the influence of primary characteristics and explore the source of heterogeneity, we conducted a series of subgroup analyses. In addition, we conducted a sensitive analysis to test the stability of the overall results by sequentially taking out one study each time, a cumulative meta-analysis to portray the shift of the association over time by adding studies one by one based on publication date, and a trial sequential analysis (TSA) to minimize the risk of type I errors. Furthermore, we performed Galbraith plot to facilitate the examination of heterogeneous studies. For the evaluation of publication bias, Egger's regression test were performed. Funnel plots and Egger's publication-bias plots were also generated in the process. All analyses were conducted using STATA software version 12.0 and TSA software version 0.9 beta. Two-tailed *p* values \<0.05 were considered as statistically significant.

Results {#sec012}
=======

Literature selection {#sec013}
--------------------

The initial search generated 162 relevant records, of which 32 were duplicates. After reviewing the abstracts of the remaining 130 records, 104 records were ruled out as irrelevant articles, reviews, letters or case-reports. The full texts of the left 26 potential publications were obtained and reviewed. Among them, three publications without sufficient data \[[@pone.0166892.ref044]--[@pone.0166892.ref047]\], one with duplicated data \[[@pone.0166892.ref043]\], and four out of HWE \[[@pone.0166892.ref039]--[@pone.0166892.ref042]\] were excluded. Eventually, 12 studies from 11 publications \[[@pone.0166892.ref028]--[@pone.0166892.ref038]\] were included in the meta-analysis. [Fig 1](#pone.0166892.g001){ref-type="fig"} illustrates the process of search and selection. [S2 File](#pone.0166892.s006){ref-type="supplementary-material"} details the excluded articles and the reasons for their exclusion, as well as the original data obtained from the author via e-mail. No genome-wide association studies (GWAS) was found on this topic.

![Flow diagram of search and selection for studies.](pone.0166892.g001){#pone.0166892.g001}

Characteristics of included studies {#sec014}
-----------------------------------

[Table 2](#pone.0166892.t002){ref-type="table"} summarizes the primary characteristics of the 12 studies finally included in the analysis. As for ethnicity, there are four studies from three publications \[[@pone.0166892.ref034], [@pone.0166892.ref036], [@pone.0166892.ref038]\] conducted in Asians, whereas eight studies \[[@pone.0166892.ref028]--[@pone.0166892.ref033], [@pone.0166892.ref035], [@pone.0166892.ref037]\] in Caucasians. All articles are in English, except one in Spanish with English abstract \[[@pone.0166892.ref032]\].

10.1371/journal.pone.0166892.t002

###### Primary characteristics of the 12 studies included in the meta-analysis.
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  Study                                                                            Study location   Ethnicity   Sourceofcontrol   Age      Definition ofIRM   Samples size   Genotypingmethod   Case   Control   Qualityscore                                          
  -------------------------------------------------------------------------------- ---------------- ----------- ----------------- -------- ------------------ -------------- ------------------ ------ --------- -------------- ----------- ------- ---------- ------- ----
  Babbage,2001 \[[@pone.0166892.ref028]\]                                          UK               Caucasian   HB                21--45   30--58             ≥3             43                 73     116       PCR-ASA        1/12/30     0.876   3/14/56    0.107   7
  Reid,2001 \[[@pone.0166892.ref029]\]                                             UK               Caucasian   HB                \-       \-                 ≥2             17                 43     60        PCR-RFLP       2/6/9       0.536   1/13/29    0.744   2
  Pietrowski,2004 \[[@pone.0166892.ref030]\]                                       Germany          Caucasian   PB                33       58                 ≥3             168                212    380       PCR            2/33/133    0.977   4/41/167   0.432   7
  Kamali,2005 \[[@pone.0166892.ref031]\]                                           Iran             Caucasian   PB                18--42   \-                 ≥3             131                143    274       PCR-ASO        0/14/117    0.518   0/21/122   0.343   6
  Quintero,2006[^a^](#t002fn002){ref-type="table-fn"} \[[@pone.0166892.ref032]\]   Mexico           Caucasian   PB                \-       \-                 ≥3             122                214    336       PCR            1/8/113     0.067   2/30/182   0.544   5
  Zammiti,2009 \[[@pone.0166892.ref033]\]                                          Tunisia          Caucasian   PB                29       29                 ≥3             372                274    646       PCR-RFLP       14/39/319   0       5/47/222   0.187   10
  Liu,2010 \[[@pone.0166892.ref034]\]                                              China            Asian       HB                30       29                 ≥2             132                152    284       PCR            0/22/110    0.296   1/13/138   0.276   6
  Palmirotta,2010 \[[@pone.0166892.ref035]\]                                       Italy            Caucasian   PB                37       38                 ≥2             100                100    200       PCR            0/13/87     0.487   3/21/76    0.313   5
  Gupta,2012 \[[@pone.0166892.ref036]\]                                            India            Asian       PB                \-       \-                 ≥3             300                500    800       PCR-RFLP       9/62/229    0.067   5/70/425   0.274   7
  Alkhuriji,2013 \[[@pone.0166892.ref037]\]                                        Saudi Arabia     Caucasian   HB                34       \-                 ≥3             65                 65     130       PCR-SSP        8/24/33     0.282   4/14/47    0.059   7
  Lee1,2013 \[[@pone.0166892.ref038]\]                                             South Korea      Asian       PB                33       33                 ≥2             187                236    423       PCR-RFLP       1/21/165    0.711   2/21/213   0.083   8
  Lee2,2013 \[[@pone.0166892.ref038]\]                                             South Korea      Asian       PB                33       33                 ≥3             170                236    406       PCR-RFLP       1/15/154    0.353   2/21/213   0.083   9

PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphism; PCR-ASA, polymerase chain reaction-allele specific amplification; PCR-ASO, polymerase chain reaction-allele specific oligonucleotide; PCR-SSP, polymerase chain reaction-sequence specific primers; HWE, Hardy-Weinberg equilibrium; PB, population based; HB, hospital based

^a^, this article is in Spanish with English abstract.

Meta-analysis results {#sec015}
---------------------

[Table 3](#pone.0166892.t003){ref-type="table"} presents the primary results of all five genetic models in this comprehensive meta-analysis. No significant association was detected in the overall meta-analysis. As there were one studies \[[@pone.0166892.ref031]\] with zero AA phenotype in both cases and controls, the overall meta-analysis was performed with only 11 studies in the homozygous model (AA vs. GG) and the recessive model (AA vs. GA + GG). The subgroup meta-analyses showed significant associations in Asian subjects in the dominant model, the allele model, and the heterozygote model between *TNF-α* -308G/A and IRM risk ([Fig 2](#pone.0166892.g002){ref-type="fig"}). Similar results were found in the hospital-based-control group and the total-sample-size \<150 group. No significant associations were found in any of the subgroups classified by the definition of IRM, the score or the Galbraith plot.

![Forest plots for the association between *TNF-α* -308G/A Polymorphism and IRM risk classified by ethnicity in dominant model (A) and allelic model (B).](pone.0166892.g002){#pone.0166892.g002}
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###### Primary results of overall meta-analyses and subgroup analyses.
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  Comparison                Group             No. of studies   Test of association   Effect model             Test of heterogeneity                           
  ------------------------- ----------------- ---------------- --------------------- ------------------------ ----------------------- ------------ ---------- -----------
  **-308G/A (rs1800629)**                     **12**                                                                                                          
  **AA vs.GG**              **Overall**       **11**^**a**^    **1.49**              **(0.93,2.40)**          **0.098**               **fixed**    **4.7**    **0.399**
  **AG vs.GG**              **Overall**       **12**           **1.06**              **(0.77,1.46)**          **0.716**               **random**   **63.7**   **0.001**
  **AA vs.AG + GG**         **Overall**       **11**^**a**^    **1.27**              **(0.77,2.10)**          **0.344**               **fixed**    **0**      **0.692**
  **AA + AG vs.GG**         **Overall**       **12**           **1.08**              **(0.79,1.47)**          **0.632**               **random**   **65**     **0.001**
  Ethnicity                 Asian             4                1.52                  **(1.17,1.98)**^**s**^   0.002                   fixed        10.2       0.342
  Caucasian                 8                 0.91             (0.62,1.34)           0.639                    random                  61.1         0.012      
  Definition of IRM         ≥3 miscarriages   8                1.05                  (0.72,1.52)              0.818                   random       69.5       0.002
  ≥2 miscarriages           4                 1.17             (0.61,2.24)           0.637                    random                  64.2         0.039      
  Source of control         HB                4                1.97                  **(1.31,2.95)**^**s**^   0.001                   fixed        0          0.796
  PB                        8                 0.87             (0.61,1.23)           0.436                    random                  67           0.003      
  Total sample size         \<150             3                1.96                  **(1.20,3.22)**^**s**^   0.008                   fixed        0          0.600
  \>150                     9                 0.94             (0.67,1.32)           0.725                    random                  67.5         0.002      
  Score                     ≤6                5                0.85                  (0.46,1.59)              0.612                   random       67.4       0.016
  \>6                       7                 1.23             (0.88,1.72)           0.229                    random                  61.4         0.016      
  Galbraith plot            insiders^b^       8                1.03                  (0.81,1.31)              0.834                   fixed        33.9       0.158
  outliers^c^               4                 1.11             (0.56,2.20)           0.760                    random                  85.3         0          
  **A vs. G**               **Overall**       **12**           **1.08**              **(0.82,1.43)**          **0.595**               **random**   **65.3**   **0.001**
  Ethnicity                 Asian             4                1.49                  **(1.17,1.90)**^**s**^   0.001                   fixed        24.1       0.267
  Caucasian                 8                 0.94             (0.66,1.44)           0.728                    random                  63.4         0.008      
  Definition of IRM         ≥3 miscarriages   8                1.06                  (0.77,1.48)              0.714                   random       67.9       0.003
  ≥2 miscarriages           4                 1.13             (0.60,2.15)           0.706                    random                  69.8         0.019      
  Source of control         HB                4                1.78                  **(1.25,2.53)**^**s**^   0.001                   fixed        0          0.687
  PB                        8                 0.90             (0.64,1.24)           0.485                    random                  68.8         0.002      
  Total sample size         \<150             3                1.79                  **(1.19,2.70)**^**s**^   0.005                   fixed        0          0.478
  \>150                     9                 0.95             (0.69,1.30)           0.743                    random                  67.7         0.002      
  Score                     ≤6                5                0.86                  (0.47,1.57)              0.631                   random       69.9       0.01
  \>6                       7                 1.23             (0.92,1.64)           0.166                    random                  57.3         0.029      
  Galbraith plot            insiders^b^       8                1.01                  (0.81,1.26)              0.947                   fixed        29.1       0.196
  outliers^c^               4                 1.13             (0.62,2.07)           0.688                    random                  85.2         0          

CI, confidence interval; OR, odds ratio; IRM, idiopathic recurrent miscarriage; ^a^, one studies \[[@pone.0166892.ref031]\] are not analyzed due to 0 AA genotype in both case and control group; Of the 12 studies included in this meta-analysis, 8 studies from 7 articles \[[@pone.0166892.ref028]--[@pone.0166892.ref032], [@pone.0166892.ref034], [@pone.0166892.ref038]\] are insiders^b^, 4 studies \[[@pone.0166892.ref033], [@pone.0166892.ref035]--[@pone.0166892.ref037]\] are outliners^c^ in Galbraith plot ([S1 Fig](#pone.0166892.s001){ref-type="supplementary-material"}); ^s^, significant results.

Publication bias {#sec016}
----------------

The results of Egger's test confirmed that no significant publication bias existed in our meta-analysis ([S3 File](#pone.0166892.s007){ref-type="supplementary-material"}). Furthermore, Funnel plot ([Fig 3](#pone.0166892.g003){ref-type="fig"}), Egger's publication-bias plot ([S3 File](#pone.0166892.s007){ref-type="supplementary-material"}) of the 12 studies demonstrated no sign of significant publication bias.

![Funnel plot of the 12 studies included in this meta-analysis.](pone.0166892.g003){#pone.0166892.g003}

Heterogeneity analysis {#sec017}
----------------------

*I*^*2*^ and *P*~*Q*~ values showed significant heterogeneity among the 12 studies in 3 genetic models (AG vs. GG; AA + GA vs. GG; A vs. G), whereas 2 genetic models (AA vs. GG; AA vs. AG + GG) with 11 studies available for analysis demonstrated little heterogeneity ([Table 3](#pone.0166892.t003){ref-type="table"}). Galbraith plot ([S1 Fig](#pone.0166892.s001){ref-type="supplementary-material"}) of the included 12 studies confirmed the existence of significant heterogeneity and illustrated 4 studies \[[@pone.0166892.ref033], [@pone.0166892.ref035]--[@pone.0166892.ref037]\] were the outliners. All the subgroup analyses showed a decline in heterogeneity in at least one subgroup, except the subgroups classified by the definition of IRM ([Table 3](#pone.0166892.t003){ref-type="table"}).

Sensitivity analysis {#sec018}
--------------------

In the sensitivity analysis, the pooled standardized mean difference (SMD) and 95% CIs were not significantly affected, no matter which study was taken out. ([S2 Fig](#pone.0166892.s002){ref-type="supplementary-material"}).

Cumulative meta-analysis {#sec019}
------------------------

In the cumulative meta-analysis, no significant association between *TNF-α* -308G/A and IRM ever appeared over time ([S3 Fig](#pone.0166892.s003){ref-type="supplementary-material"}).

Trial sequential analysis {#sec020}
-------------------------

Repeated tests for significance upon new trials by meta-analyses may incur type I error \[[@pone.0166892.ref052]\]. To evaluate and minimize it, TSA was employed using software version 0.9 beta \[[@pone.0166892.ref053]\]. TSA combines traditional meta-analysis with information size calculation, and methods to adjust the significance according to the quantified strength of evidence and the impact of multiplicity for the repeated tests on accumulating trial data. In the present analysis, TSA was performed in dominant model with a two-tailed alpha of 0.05, beta of 0.20, and a relative risk increase of 10%. And a constant value correction of 0.5 in the no event trials was applied. The result of TSA demonstrates that neither the traditional significance boundaries nor the α-spending boundaries is crossed by the cumulative z-curve (dominant model) ([Fig 4](#pone.0166892.g004){ref-type="fig"}).

![Trial sequential analysis of the studies included.\
A two-sided graph is plotted by TSA where the blue etched lines represent conventional significance boundaries, the blue line indicates the cumulative Z-score, and the red lines shows the α -spending boundary and the required information size.](pone.0166892.g004){#pone.0166892.g004}

Discussion {#sec021}
==========

The present meta-analysis enrolled 12 studies from 11 publications with 1,807 cases and 2,012 controls to assess the correlation between *TNF-α* -308G/A polymorphism and IRM risk. In addition, this meta-analysis presented the first cumulative meta-analysis and the first trial sequential analysis on this topic. In the cumulative meta-analysis, we found no trend of association, and more stable CIs with the accumulation of studies based on publication dates ([S3 Fig](#pone.0166892.s003){ref-type="supplementary-material"}). The trial sequential analysis shows a parallel cumulative z-curve to both the conventional boundaries and the α-spending boundaries ([Fig 4](#pone.0166892.g004){ref-type="fig"}), which indicates and confirms the inexistence of association between *TNF-α* -308G/A and IRM ([S4 Fig](#pone.0166892.s004){ref-type="supplementary-material"}). Sensitivity analysis also demonstrated that the overall results were reliable and robust, with no single influential study. All in all, the overall analyses found no significant associations in all five genetic models, which is quite opposite to the results of two recent meta-analyses in 2012 and 2016 \[[@pone.0166892.ref049], [@pone.0166892.ref050]\], whereas consistent with the meta-analysis in 2009 \[[@pone.0166892.ref048]\] and two reviews about the effect of polymorphisms of TNF-α\[[@pone.0166892.ref054], [@pone.0166892.ref055]\].

Since the main difference between the present meta-analysis and the previous meta-analyses \[[@pone.0166892.ref048]--[@pone.0166892.ref050]\], primarily lies in the exclusion and inclusion of studies without sufficient data to calculate HWE \[[@pone.0166892.ref044]--[@pone.0166892.ref047]\], and studies deviating from HWE \[[@pone.0166892.ref039]--[@pone.0166892.ref041]\] ([Table 4](#pone.0166892.t004){ref-type="table"}). After looking into the previous meta-analyses with great care, we noticed that some data could not be found in the original manuscripts \[[@pone.0166892.ref031], [@pone.0166892.ref044]--[@pone.0166892.ref046]\] were listed out and analyzed in the meta-analyses in 2009 \[[@pone.0166892.ref048]\] and 2012 \[[@pone.0166892.ref049]\], and some studies without sufficient data to calculate HWE \[[@pone.0166892.ref028], [@pone.0166892.ref031], [@pone.0166892.ref045], [@pone.0166892.ref046]\] were included and analyzed in the meta-analysis in 2016 \[[@pone.0166892.ref050]\] ([Table 4](#pone.0166892.t004){ref-type="table"}). The possibility exists that the suspicious data in the meta-analysis in 2012 may be obtained from authors directly. Hence, an additional meta-analysis was conducted with these suspected data, and the primary results remain unchanged ([S4 File](#pone.0166892.s008){ref-type="supplementary-material"}). Therefore, we may conclude that the associations found in previous meta-analyses were skewed due to the studies inconsistent with HWE. After all, departure from HWE can indicate systematic errors in genotyping, and data generated under this condition were unreliable and may significantly affects the conclusions of meta-analysis, which is the reason why HWE was ranked as an essential and routine item of the scrutinizing procedure in population-based genetic association meta-analyses ([S2 Table](#pone.0166892.s011){ref-type="supplementary-material"}, Item 9) \[[@pone.0166892.ref056]\].

10.1371/journal.pone.0166892.t004

###### Primary differences between previous meta-analyses and the present meta-analysis on the association of *TNF-α* -308G/A Polymorphism and IRM.
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  Author/Year                                  Country        Original data (genotype frequency)   HWE         Definition of IRM                            Data in the Meta-analysis of 2009\[[@pone.0166892.ref047]\]   Data in the Meta-analysis of 2012\[[@pone.0166892.ref048]\]   Data in the Meta-analysis of 2016\[[@pone.0166892.ref049]\]   Data in the present meta-analysis                                                                                                                                                                                                                           
  -------------------------------------------- -------------- ------------------------------------ ----------- -------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------- --------------------------------------------------- --------------------------------------------------- ------------------------------------------------ ------------------------------------------------ ------------------------------------------------- -------------------------------------------------
  Babbage, 2001\[[@pone.0166892.ref028]\]      UK             1/12/30                              3/14/56     Y                                            ≥3                                                            1/12/30                                                       3/14/56                                                       1/12/30                                             3/14/56                                             13/30                                            17/56                                            1/12/30                                           3/14/56
  Baxter, 2001\[[@pone.0166892.ref044]\]       UK             \-                                   \-          \-                                           ≥3                                                            *25/51*[^*b*^](#t004fn003){ref-type="table-fn"}               *44/94*[^*b*^](#t004fn003){ref-type="table-fn"}               *3/22/51*[^*b*^](#t004fn003){ref-type="table-fn"}   *5/40/93*[^*b*^](#t004fn003){ref-type="table-fn"}   \-                                               \-                                               \-                                                \-
  Reid, 2001\[[@pone.0166892.ref029]\]         UK             2/6/9                                1/13/29     Y                                            ≥2                                                            2/6/9                                                         1/13/29                                                       2/6/9                                               1/13/29                                             excluded[^e^](#t004fn006){ref-type="table-fn"}   excluded[^e^](#t004fn006){ref-type="table-fn"}   2/6/9                                             1/13/29
  Daher, 2003\[[@pone.0166892.ref045]\]        Brazil         12/36                                19/89       \-                                           ≥3                                                            12/36                                                         19/89                                                         1/11/36 [^*b*^](#t004fn003){ref-type="table-fn"}    1/18/89 [^*b*^](#t004fn003){ref-type="table-fn"}    12/36                                            19/89                                            excluded[^d^](#t004fn005){ref-type="table-fn"}    excluded[^d^](#t004fn005){ref-type="table-fn"}
  Pietrowski, 2004\[[@pone.0166892.ref030]\]   Germany        2/33/133                             4/41/167    Y                                            ≥3                                                            2/33/133                                                      4/41/167                                                      2/33/133                                            4/41/167                                            2/33/133                                         4/41/167                                         2/33/133                                          4/41/167
  Prigoshin, 2004\[[@pone.0166892.ref046]\]    Argentina      6/35                                 5/49        \-                                           ≥3                                                            6/35                                                          5/49                                                          0/6/35 [^*b*^](#t004fn003){ref-type="table-fn"}     0/5/49 [^*b*^](#t004fn003){ref-type="table-fn"}     6/35                                             5/49                                             excluded[^d^](#t004fn005){ref-type="table-fn"}    excluded[^d^](#t004fn005){ref-type="table-fn"}
  Kamali, 2005\[[@pone.0166892.ref031]\]       Iran           14/117                               21/122      -/Y [^c^](#t004fn004){ref-type="table-fn"}   ≥3                                                            14/117                                                        21/122                                                        0/14/117 [^*b*^](#t004fn003){ref-type="table-fn"}   0/21/122 [^*b*^](#t004fn003){ref-type="table-fn"}   14/117                                           21/122                                           0/14/117 [^c^](#t004fn004){ref-type="table-fn"}   0/21/122 [^c^](#t004fn004){ref-type="table-fn"}
  Quintero, 2006\[[@pone.0166892.ref032]\]     Mexico         1/8/113                              2/30/182    Y                                            ≥3                                                            missing                                                       missing                                                       missing                                             missing                                             missing                                          missing                                          1/8/113                                           2/30/182
  Zammiti, 2009\[[@pone.0166892.ref033]\]      Tunisia        14/39/319                            5/47/222    Y                                            ≥3                                                                                                                                                                                        14/39/319                                           5/47/222                                            14/39/319                                        5/47/222                                         14/39/319                                         5/47/222
  Finan, 2010\[[@pone.0166892.ref039]\]        Bahrain        8/32/164                             4/32/212    N                                            ≥3                                                                                                                                                                                        8/32/164                                            4/32/212                                            8/32/164                                         4/32/212                                         excluded[^d^](#t004fn005){ref-type="table-fn"}    excluded[^d^](#t004fn005){ref-type="table-fn"}
  Liu, 2010\[[@pone.0166892.ref034]\]          China          0/22/110                             1/13/138    Y                                            ≥2                                                                                                                                                                                        0/22/110                                            1/13/138                                            excluded[^e^](#t004fn006){ref-type="table-fn"}   excluded[^e^](#t004fn006){ref-type="table-fn"}   0/22/110                                          1/13/138
  Palmirotta, 2010\[[@pone.0166892.ref035]\]   Italy          0/13/87                              3/21/76     Y                                            ≥2                                                                                                                                                                                        0/13/87                                             3/21/76                                             excluded[^e^](#t004fn006){ref-type="table-fn"}   excluded[^e^](#t004fn006){ref-type="table-fn"}   0/13/87                                           3/21/76
  Kaur, 2011\[[@pone.0166892.ref040]\]         India          5/6/39                               2/7/41      N                                            ≥3                                                                                                                                                                                                                                                                                                5/6/39                                           2/7/41                                           excluded[^d^](#t004fn005){ref-type="table-fn"}    excluded[^d^](#t004fn005){ref-type="table-fn"}
  Gupta, 2012\[[@pone.0166892.ref036]\]        India          9/62/229                             5/70/425    Y                                            ≥3                                                                                                                                                                                                                                                                                                9/62/229                                         5/70/425                                         9/62/229                                          5/70/425
  Alkhuriji, 2013\[[@pone.0166892.ref037]\]    Saudi Arabia   8/24/33                              4/14/47     Y                                            ≥3                                                                                                                                                                                                                                                                                                8/24/33                                          4/14/47                                          8/24/33                                           4/14/47
  Lee1, 2013\[[@pone.0166892.ref038]\]         South Korea    1/21/165                             2/21/213    Y                                            ≥2                                                                                                                                                                                                                                                                                                excluded[^e^](#t004fn006){ref-type="table-fn"}   excluded[^e^](#t004fn006){ref-type="table-fn"}   1/21/165                                          2/21/213
  Lee2, 2013\[[@pone.0166892.ref038]\]         South Korea    1/15/154                             2/21/213    Y                                            ≥3                                                                                                                                                                                                                                                                                                missing                                          Missing                                          1/15/154                                          2/21/213
  Bompeixe, 2013\[[@pone.0166892.ref047]\]     Brazil         16/45                                16/59       \-                                           ≥2                                                                                                                                                                                                                                                                                                excluded[^e^](#t004fn006){ref-type="table-fn"}   excluded[^e^](#t004fn006){ref-type="table-fn"}   excluded[^d^](#t004fn005){ref-type="table-fn"}    excluded[^d^](#t004fn005){ref-type="table-fn"}
  Liu, 2015\[[@pone.0166892.ref041]\]          China          35/105/144                           18/61/205   N                                            ≥3                                                                                                                                                                                                                                                                                                                                                                                                  excluded[^d^](#t004fn005){ref-type="table-fn"}    excluded[^d^](#t004fn005){ref-type="table-fn"}
  Sudhir, 2016\[[@pone.0166892.ref042]\]       India          5/34/76                              6/18/87     N                                            ≥2                                                                                                                                                                                                                                                                                                                                                                                                  excluded[^d^](#t004fn005){ref-type="table-fn"}    excluded[^d^](#t004fn005){ref-type="table-fn"}

HWE, Hardy-Weinberg equilibrium; -, data that could not be extracted from the original publications or calculated from genotype frequencies extracted; data in italic and bold, dubious and conflicting data found in two different meta-analyses

^a^, data of genotype frequency are sequenced in the order of AA/AG/GG, OR AA+AG/GG

^b^, dubious data found in the meta-analysis in 2012, but could not be found in the original publications

^c^, data obtained via e-mail from author

^d^, studies excluded due to deviating from HWE or insufficient data to calculate HWE

^e^, studies excluded because of different definition of IRM (In these studies, the authors adopted the definition of IRM as ≥2 consecutive spontaneous miscarriages, instead of ≥3 consecutive spontaneous miscarriages).

What is more, we conducted several stratified analyses to trace the possible sources of the heterogeneity and found several points noteworthy. First, as for the definition of IRM, no significant difference was shown between the ≥2 miscarriages group and the ≥3 miscarriages group ([Table 3](#pone.0166892.t003){ref-type="table"}), indicating that the different definition of IRM is not the possible cause of heterogeneity. Similar result was also found by Lee et al \[[@pone.0166892.ref038]\], who performed stratified analysis according to the number of consecutive spontaneous abortions in the study. In practice, most clinicians generally work to the less rigorous ≥2 miscarriages definition, probably because patients will be extremely worried under this condition and it is doctor's responsibility to address their problems. Second, in addition to the significant association, a lower heterogeneity was also seen in the Asian populations compared to the Caucasian populations. On one hand, it is possible that the association between *TNF-α* -308G/A polymorphism and IRM risk is of ethnic specificity. However, this result should be interpreted with care, since the association found in the Asian population was supported by four studies from only three publications, which is far from sufficient. On the other hand, the low heterogeneity may be due to the limited studies themselves. Third, eight insiders and four outliers discovered in Galbraith plot were classified and analyzed, and a remarkable decrease of heterogeneity were demonstrated among the 8 insiders in the dominant model (*I*^*2*^ 33.9) and the allelic model (*I*^*2*^ 29.1), indicating the four outliners may be the cause of the heterogeneity ([Table 3](#pone.0166892.t003){ref-type="table"}). Fourth, there are signs of possible sample-selection bias. As mentioned above, one study \[[@pone.0166892.ref034]\] with zero AA genotype frequency in both cases and controls, is not included in the overall meta-analyses of both the homozygous model (AA vs. GG) and the recessive model (AA vs. GA + GG). And a significant decrease in heterogeneity is demonstrated in both model (with *I*^*2*^ 4.7 and 0, respectively). One possible explanation is that either the cases or the controls in this study are not representative. Another indication is that the heterogeneity of the total-sample-size \>150 group was significantly higher than that of its counterpart group.

More importantly, during this meta-analysis, we summarized several meaningful points that may be helpful to further studies. First, the inclusion and exclusion criteria must be specific and comprehensive and should be strictly carried out. Otherwise, confounding factors will inevitably be mixed in. Second, more studies on Asian populations are needed. Third, more attention should be paid to the selection of the control group, which is always neglected and carried out without strictly following criteria. Four studies \[[@pone.0166892.ref039]--[@pone.0166892.ref042]\] deviating from HWE and one study with 0 AA genotype frequency in both cases and controls \[[@pone.0166892.ref031]\], are good representations of this issue.

There are some limitations in the present meta-analysis, which should be noted. First, misclassification bias and selection bias may be incurred due to unified diagnostic criteria of IRM and various sources of controls. Second, we failed to evaluate the gene-gene and gene-environment associations due to lack of the original data. Third, heterogeneity in several subgroups remains high in the subgroup analyses. Last but not least, the limited number of studies in Asian population may restrict the statistical power of the association.

In summary, no association between the *TNF-α* -308G/A promoter polymorphism and IRM was found in the present meta-analysis. The correlation found in Asian population needs confirmation from more studies.

Conclusions {#sec022}
===========

The present meta-analysis demonstrated no association between *TNF-α* -308G/A polymorphism and IRM risk, and the association found in the previous meta-analyses may result from the inclusion of studies inconsistent with HWE. Significant association demonstrated in Asian subjects in the subgroup analyses, should be interpreted with caution due to limited studies. Further rigorously-designed large-scale studies on Asian population are needed to confirm this conclusion.
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